Schulenburg, Johann-Matthias von der (contributor); … - 2008
have to be offset by the costs of regulation. These costs consist first of direct costs due to the regulation itself, since … costs of regulation in the German pharmacy sector. It then describes the deregulation measures needed to avoid regulation … investment in drug distribution. In contrast to the present situation, Germany could be a pioneer with regard to the regulation …
